DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFlu

Drug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fKfljM
via IFTTT